Navigation Links
GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.

ProductsGeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
Company GeneChoice, Inc.
Item GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor
Price $142.00
Description Ribonuclease Inhibitor is a recombinant protein that has been shown to help maintain the integrity of RNA in the preparation of cDNA by reverse transcription, in vitro RNA transcription, and in vitro protein synthesis. RNA Safe Inhibitor tightly binds RNases in a 1:1 ratio. It inhibits a broad range of eukaryotic RNases such as RNase A, RNase B, RNase C, and human placental RNase. RNA Safe does not interfere with the performance of other enzymes in the reaction. • RNA Safe is most effective between pH 5.5 and 8.0. It does not inhibit AMV or MMLV reverse transcriptases; SP6, T3, and T7 RNA polymerases; Taq DNA polymerase; RNase H; RNase T1; or S1 Nuclease. • Efficient inhibition of ribonucleases •Protects RNA during cDNA synthesis and in vitro transcription/translation.

  • Applications: First and second strand cDNA synthesis, RT-PCR, and in vitro transcription and translation.
  • Unit Definition: One unit of protein inhibits the activity of 5 ng RNase A by 50%.
  • Enzyme Concentration: 40 to 50 units/µl.
  • Supplied As: 5,000 units.
  • Storage Conditions: Store at -20°C.
Info GeneChoice, Inc.GeneChoice, Inc.
7307 Governors Way
Frederick, MD 21703 USA

Call GeneChoice, Inc. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-772-8354
Customer Service: 866-636-2200
Fax Number: 301-620-0162
Web Site: http://www.genechoiceinc.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GeneChoice Taq DNA Polymerase With Standard Buffer from GeneChoice, Inc.
2. GeneChoice Taq DNA Polymerase With Ammonium Buffer from GeneChoice, Inc.
3. GeneChoice Taq DNA Polymerase With Magnesium Free Standard Buffer from GeneChoice, Inc.
4. GeneChoice TEMPase II DNA Polymerase from GeneChoice, Inc.
5. Recombinant Expression of Peptides and Proteins: from rPeptide, LLC
6. Recombinant RNasin® Ribonuclease Inhibitor from Promega
7. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
8. hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate
9. hERG-CHO K1 Recombinant Cell Line from Upstate
10. hERG-CHO K1 Recombinant Cell Line from Upstate
11. hHCN4-CHO K1 Recombinant Cell Line from Upstate
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality ... Several trends in analytical testing are being attributed to new regulatory requirements for ...
(Date:10/11/2017)... ... ... is a basic first aid supply for any work environment, but most personal eye wash ... if a dangerous substance enters both eyes? It’s one less decision, and likely quicker response ... piece. , “Whether its dirt and debris, or an acid or alkali, getting anything in ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
Breaking Biology Technology: